Dr. Scott M. Belliston, DO

Dr. Belliston practices at Sanford Fargo Hospice in Fargo, North Dakota.

Dr. Belliston's NPI, 1235423393, was assigned on June 7, 2011. Dr. Belliston graduated from Michigan State University College Of Osteopathic Medicine in 2011. Dr. Belliston holds North Dakota license 16749.

Dr. Belliston's primary practice is Sanford Fargo Hospice, at 801 Broadway North, Fargo, ND 58102 in Cass County. The practice phone is (701) 234-7550.

Dr. Belliston's primary practice is Sanford Fargo Hospice in Fargo, North Dakota. Dr. Belliston is also affiliated with Sanford Broadway Medical Center. The medical group on file is Sanford West Fargo Clinic. Dmand AI also links Dr. Belliston to 4 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Belliston practices, 6 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Belliston's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Belliston is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Belliston's licenses on file in 2 states: North Dakota and Kansas.

Dmand AI lists encephalopathy, epilepsy, fibromyalgia and chronic pain, hereditary polyneuropathy, lower back pain, migraine and chronic headache, mobility impairment and multiple sclerosis among the conditions Dr. Belliston treats.

CMS data shows 496 Medicare services from Dr. Belliston across 10 procedure codes in 2024, for 248 Medicare patients. Medicare paid $35,419 for them.

CMS counts 248 Medicare patients who saw Dr. Belliston in 2024. The largest group is 65 to 74, with 88 patients. 71% of them have high cholesterol, and 68% have high blood pressure. 30% are also on Medicaid. Their average risk score is 1.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Belliston's median patient age at 65, with 62% women.

In 2024, Dr. Belliston wrote 1,267 Medicare Part D claims for 171 patients. 88% of them were for generic drugs. CMS names the drug for 1,065 of them, across 32 drugs with 11 or more claims each, at $786,274 in total drug cost. In 2023, CMS named 850 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Belliston for performance year 2024, reported as part of a group. Dr. Belliston accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Belliston as offering telehealth.

Dmand AI links 3 papers to Dr. Belliston, published from 2016 to 2017. 2016 was the busiest year, with 2. The most frequent topics are Multiple Sclerosis, Relapsing-Remitting. Dr. Belliston's most frequent co-author is Nancy E. Hammond, MD.

Dmand AI links Dr. Belliston to 2 clinical trials. 2 are still active or recruiting. Conditions studied include Multiple Sclerosis and Demyelinating Autoimmune Diseases, CNS. Sanofi sponsors the most, 2.

CMS Open Payments shows 174 general payments to Dr. Belliston from 33 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 52% of the total. UCB, Inc. paid the most, $3,099.

Dr. Belliston graduated from Michigan State University College Of Osteopathic Medicine in 2011. Dr. Belliston is a member of AAN.

Dr. Belliston is in network with 17 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.